+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Compounding Pharmacy Market 2025-2029

  • PDF Icon

    Report

  • 199 Pages
  • January 2025
  • Region: Global
  • TechNavio
  • ID: 5681530
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The compounding pharmacy market is forecasted to grow by USD 1.74 billion during 2024-2029, accelerating at a CAGR of 2.2% during the forecast period. The report on the compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of HRT fueling demand for compounded medications, increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The compounding pharmacy market is segmented as below:

By Product

  • Topical medications
  • Oral medications
  • Parenteral medications
  • Others

By Therapeutic Area

  • Pain management
  • Hormone replacement
  • Dermal disorders
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and global shortage of essential drugs will lead to sizable demand in the market.

The report on the compounding pharmacy market covers the following areas:

  • Compounding Pharmacy Market sizing
  • Compounding Pharmacy Market forecast
  • Compounding Pharmacy Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading compounding pharmacy market vendors that include ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius Kabi AG, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. Also, the compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Compounding Pharmacy Market 2019 - 2023
Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Compounding Pharmacy Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Topical medications - Market size and forecast 2024-2029
Chart on Topical medications - Market size and forecast 2024-2029 ($ million)
Data Table on Topical medications - Market size and forecast 2024-2029 ($ million)
Chart on Topical medications - Year-over-year growth 2024-2029 (%)
Data Table on Topical medications - Year-over-year growth 2024-2029 (%)
8.4 Oral medications - Market size and forecast 2024-2029
Chart on Oral medications - Market size and forecast 2024-2029 ($ million)
Data Table on Oral medications - Market size and forecast 2024-2029 ($ million)
Chart on Oral medications - Year-over-year growth 2024-2029 (%)
Data Table on Oral medications - Year-over-year growth 2024-2029 (%)
8.5 Parenteral medications - Market size and forecast 2024-2029
Chart on Parenteral medications - Market size and forecast 2024-2029 ($ million)
Data Table on Parenteral medications - Market size and forecast 2024-2029 ($ million)
Chart on Parenteral medications - Year-over-year growth 2024-2029 (%)
Data Table on Parenteral medications - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Therapeutic Area
9.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
9.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
9.3 Pain management - Market size and forecast 2024-2029
Chart on Pain management - Market size and forecast 2024-2029 ($ million)
Data Table on Pain management - Market size and forecast 2024-2029 ($ million)
Chart on Pain management - Year-over-year growth 2024-2029 (%)
Data Table on Pain management - Year-over-year growth 2024-2029 (%)
9.4 Hormone replacement - Market size and forecast 2024-2029
Chart on Hormone replacement - Market size and forecast 2024-2029 ($ million)
Data Table on Hormone replacement - Market size and forecast 2024-2029 ($ million)
Chart on Hormone replacement - Year-over-year growth 2024-2029 (%)
Data Table on Hormone replacement - Year-over-year growth 2024-2029 (%)
9.5 Dermal disorders - Market size and forecast 2024-2029
Chart on Dermal disorders - Market size and forecast 2024-2029 ($ million)
Data Table on Dermal disorders - Market size and forecast 2024-2029 ($ million)
Chart on Dermal disorders - Year-over-year growth 2024-2029 (%)
Data Table on Dermal disorders - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.9 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.13 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.15 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.16 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 ACPHARM QUEENSLAND Pty Ltd.
ACPHARM QUEENSLAND Pty Ltd. - Overview
ACPHARM QUEENSLAND Pty Ltd. - Product / Service
ACPHARM QUEENSLAND Pty Ltd. - Key offerings
SWOT
14.5 Advance Pharmacy
Advance Pharmacy - Overview
Advance Pharmacy - Product / Service
Advance Pharmacy - Key offerings
SWOT
14.6 B.Braun SE
B.Braun SE - Overview
B.Braun SE - Product / Service
B.Braun SE - Key news
B.Braun SE - Key offerings
SWOT
14.7 Fagron NV
Fagron NV - Overview
Fagron NV - Business segments
Fagron NV - Key offerings
Fagron NV - Segment focus
SWOT
14.8 Fresenius Kabi AG
Fresenius Kabi AG - Overview
Fresenius Kabi AG - Product / Service
Fresenius Kabi AG - Key offerings
SWOT
14.9 Institutional Pharmacy Solutions
Institutional Pharmacy Solutions - Overview
Institutional Pharmacy Solutions - Product / Service
Institutional Pharmacy Solutions - Key offerings
SWOT
14.10 ITC Compounding Pharmacy
ITC Compounding Pharmacy - Overview
ITC Compounding Pharmacy - Product / Service
ITC Compounding Pharmacy - Key offerings
SWOT
14.11 McGuff Co. Inc.
McGuff Co. Inc. - Overview
McGuff Co. Inc. - Product / Service
McGuff Co. Inc. - Key offerings
SWOT
14.12 Nephron Pharmaceuticals Corp.
Nephron Pharmaceuticals Corp. - Overview
Nephron Pharmaceuticals Corp. - Product / Service
Nephron Pharmaceuticals Corp. - Key offerings
SWOT
14.13 Olympia Pharmacy
Olympia Pharmacy - Overview
Olympia Pharmacy - Product / Service
Olympia Pharmacy - Key offerings
SWOT
14.14 PenCol Specialty Pharmacy
PenCol Specialty Pharmacy - Overview
PenCol Specialty Pharmacy - Product / Service
PenCol Specialty Pharmacy - Key offerings
SWOT
14.15 Rx3 Compounding Pharmacy
Rx3 Compounding Pharmacy - Overview
Rx3 Compounding Pharmacy - Product / Service
Rx3 Compounding Pharmacy - Key offerings
SWOT
14.16 Triangle Compounding Pharmacy
Triangle Compounding Pharmacy - Overview
Triangle Compounding Pharmacy - Product / Service
Triangle Compounding Pharmacy - Key offerings
SWOT
14.17 Valor Compounding Pharmacy
Valor Compounding Pharmacy - Overview
Valor Compounding Pharmacy - Product / Service
Valor Compounding Pharmacy - Key offerings
SWOT
14.18 Wedgewood Village Pharmacy LLC
Wedgewood Village Pharmacy LLC - Overview
Wedgewood Village Pharmacy LLC - Product / Service
Wedgewood Village Pharmacy LLC - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2024 and 2029
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value chain analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million)
Exhibits 25: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 29: Five forces analysis - Comparison between 2024 and 2029
Exhibits 30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 35: Chart on Market condition - Five forces 2024 and 2029
Exhibits 36: Chart on Product - Market share 2024-2029 (%)
Exhibits 37: Data Table on Product - Market share 2024-2029 (%)
Exhibits 38: Chart on Comparison by Product
Exhibits 39: Data Table on Comparison by Product
Exhibits 40: Chart on Topical medications - Market size and forecast 2024-2029 ($ million)
Exhibits 41: Data Table on Topical medications - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Chart on Topical medications - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Topical medications - Year-over-year growth 2024-2029 (%)
Exhibits 44: Chart on Oral medications - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Oral medications - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Oral medications - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Oral medications - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Parenteral medications - Market size and forecast 2024-2029 ($ million)
Exhibits 49: Data Table on Parenteral medications - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Chart on Parenteral medications - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Parenteral medications - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 53: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 56: Market opportunity by Product ($ million)
Exhibits 57: Data Table on Market opportunity by Product ($ million)
Exhibits 58: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 59: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 60: Chart on Comparison by Therapeutic Area
Exhibits 61: Data Table on Comparison by Therapeutic Area
Exhibits 62: Chart on Pain management - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Data Table on Pain management - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Chart on Pain management - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Pain management - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Hormone replacement - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Hormone replacement - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Hormone replacement - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Hormone replacement - Year-over-year growth 2024-2029 (%)
Exhibits 70: Chart on Dermal disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Dermal disorders - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Dermal disorders - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Dermal disorders - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 78: Market opportunity by Therapeutic Area ($ million)
Exhibits 79: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 81: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 82: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 83: Chart on Geographic comparison
Exhibits 84: Data Table on Geographic comparison
Exhibits 85: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 88: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 89: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 141: Market opportunity By Geographical Landscape ($ million)
Exhibits 142: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 143: Impact of drivers and challenges in 2024 and 2029
Exhibits 144: Overview on criticality of inputs and factors of differentiation
Exhibits 145: Overview on factors of disruption
Exhibits 146: Impact of key risks on business
Exhibits 147: Companies covered
Exhibits 148: Company ranking index
Exhibits 149: Matrix on companies position and classification
Exhibits 150: ACPHARM QUEENSLAND Pty Ltd. - Overview
Exhibits 151: ACPHARM QUEENSLAND Pty Ltd. - Product / Service
Exhibits 152: ACPHARM QUEENSLAND Pty Ltd. - Key offerings
Exhibits 153: SWOT
Exhibits 154: Advance Pharmacy - Overview
Exhibits 155: Advance Pharmacy - Product / Service
Exhibits 156: Advance Pharmacy - Key offerings
Exhibits 157: SWOT
Exhibits 158: B.Braun SE - Overview
Exhibits 159: B.Braun SE - Product / Service
Exhibits 160: B.Braun SE - Key news
Exhibits 161: B.Braun SE - Key offerings
Exhibits 162: SWOT
Exhibits 163: Fagron NV - Overview
Exhibits 164: Fagron NV - Business segments
Exhibits 165: Fagron NV - Key offerings
Exhibits 166: Fagron NV - Segment focus
Exhibits 167: SWOT
Exhibits 168: Fresenius Kabi AG - Overview
Exhibits 169: Fresenius Kabi AG - Product / Service
Exhibits 170: Fresenius Kabi AG - Key offerings
Exhibits 171: SWOT
Exhibits 172: Institutional Pharmacy Solutions - Overview
Exhibits 173: Institutional Pharmacy Solutions - Product / Service
Exhibits 174: Institutional Pharmacy Solutions - Key offerings
Exhibits 175: SWOT
Exhibits 176: ITC Compounding Pharmacy - Overview
Exhibits 177: ITC Compounding Pharmacy - Product / Service
Exhibits 178: ITC Compounding Pharmacy - Key offerings
Exhibits 179: SWOT
Exhibits 180: McGuff Co. Inc. - Overview
Exhibits 181: McGuff Co. Inc. - Product / Service
Exhibits 182: McGuff Co. Inc. - Key offerings
Exhibits 183: SWOT
Exhibits 184: Nephron Pharmaceuticals Corp. - Overview
Exhibits 185: Nephron Pharmaceuticals Corp. - Product / Service
Exhibits 186: Nephron Pharmaceuticals Corp. - Key offerings
Exhibits 187: SWOT
Exhibits 188: Olympia Pharmacy - Overview
Exhibits 189: Olympia Pharmacy - Product / Service
Exhibits 190: Olympia Pharmacy - Key offerings
Exhibits 191: SWOT
Exhibits 192: PenCol Specialty Pharmacy - Overview
Exhibits 193: PenCol Specialty Pharmacy - Product / Service
Exhibits 194: PenCol Specialty Pharmacy - Key offerings
Exhibits 195: SWOT
Exhibits 196: Rx3 Compounding Pharmacy - Overview
Exhibits 197: Rx3 Compounding Pharmacy - Product / Service
Exhibits 198: Rx3 Compounding Pharmacy - Key offerings
Exhibits 199: SWOT
Exhibits 200: Triangle Compounding Pharmacy - Overview
Exhibits 201: Triangle Compounding Pharmacy - Product / Service
Exhibits 202: Triangle Compounding Pharmacy - Key offerings
Exhibits 203: SWOT
Exhibits 204: Valor Compounding Pharmacy - Overview
Exhibits 205: Valor Compounding Pharmacy - Product / Service
Exhibits 206: Valor Compounding Pharmacy - Key offerings
Exhibits 207: SWOT
Exhibits 208: Wedgewood Village Pharmacy LLC - Overview
Exhibits 209: Wedgewood Village Pharmacy LLC - Product / Service
Exhibits 210: Wedgewood Village Pharmacy LLC - Key offerings
Exhibits 211: SWOT
Exhibits 212: Inclusions checklist
Exhibits 213: Exclusions checklist
Exhibits 214: Currency conversion rates for US$
Exhibits 215: Research methodology
Exhibits 216: Information sources
Exhibits 217: Data validation
Exhibits 218: Validation techniques employed for market sizing
Exhibits 219: Data synthesis
Exhibits 220: 360 degree market analysis
Exhibits 221: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global compounding pharmacy market: ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius Kabi AG, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising popularity of personalized medicines."

According to the report, one of the major drivers for this market is the growing popularity of hrt fueling demand for compounded medications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACPHARM QUEENSLAND Pty Ltd.
  • Advance Pharmacy
  • B.Braun SE
  • Doughertys Pharmacy
  • Fagron NV
  • Fresenius Kabi AG
  • Institutional Pharmacy Solutions
  • ITC Compounding Pharmacy
  • Lee Silsby Compounding Pharmacy
  • McGuff Co. Inc.
  • Nephron Pharmaceuticals Corp.
  • Olympia Pharmacy
  • PenCol Specialty Pharmacy
  • QuVa Pharma Inc.
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacy
  • Valor Compounding Pharmacy
  • Village Compounding Pharmacy
  • Wedgewood Village Pharmacy LLC